Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemo...
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
About this item
Full title
Author / Creator
Mittendorf, Elizabeth A , Zhang, Hong , Barrios, Carlos H , Saji, Shigehira , Jung, Kyung Hae , Hegg, Roberto , Koehler, Andreas , Sohn, Joohyuk , Iwata, Hiroji , Telli, Melinda L , Ferrario, Cristiano , Punie, Kevin , Penault-Llorca, Frédérique , Patel, Shilpen , Duc, Anh Nguyen , Liste-Hermoso, Mario , Maiya, Vidya , Molinero, Luciana , Chui, Stephen Y and Harbeck, Nadia
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Preferred neoadjuvant regimens for early-stage triple-negative breast cancer (TNBC) include anthracycline-cyclophosphamide and taxane-based chemotherapy. IMpassion031 compared efficacy and safety of atezolizumab versus placebo combined with nab-paclitaxel followed by doxorubicin plus cyclophosphamide as neoadjuvant treatment for early-stage TNBC.
Alternative Titles
Full title
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Zhang, Hong
Barrios, Carlos H
Saji, Shigehira
Jung, Kyung Hae
Hegg, Roberto
Koehler, Andreas
Sohn, Joohyuk
Iwata, Hiroji
Telli, Melinda L
Ferrario, Cristiano
Punie, Kevin
Penault-Llorca, Frédérique
Patel, Shilpen
Duc, Anh Nguyen
Liste-Hermoso, Mario
Maiya, Vidya
Molinero, Luciana
Chui, Stephen Y
Harbeck, Nadia
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_03046446v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03046446v1
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(20)31953-X
